← Back to Patent Explorer
US4515943A Expired / Lapsed US ⏱️ 0.0 years remaining

Crystal of beta-nicotinamide-adenine-dinucleotide and process for preparing the same

Assignee: Kohjin Holdings Co Ltd
•
Filing: 1983-04-19
•
Granted: 1985-05-07
•
Expires: 2003-04-19
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Novel highly pure and stable crystals of β-nicotinamide-adenine-dinucleotide tetrahydrate (NAD) which is triclinic system and has a space group of P1 or P1 and lattice constants: a=8.861 Å, b=11.181 Å, c=8.630 Å, α=90.82°, β=103.40° and γ=109.71°. The crystalline NAD is prepared by cooling a 20 to 60 w/v % aqueous solution of amorphous NAD, which has preferably been treated with a porous weakly basic anion exchange resin to remove impurities, at a temperature of 0° to 20° C. When the crystalline NAD is added to the aqueous solution as seeds, the desired high pure crystalline NAD is prepared without conducting the treatment of amorphous NAD with the porous weakly basic anion exchange resin. A high pure amorphous NAD is obtained from the crystalline NAD by dissolving the crystalline NAD in water and subjecting the aqueous solution to freeze drying or precipitation with a solvent.

Inventors

  • 👤 Toyofumi Miya
  • 👤 Yukiharu Kobayashi
  • 👤 Masao Yano

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 13:29
CPC Classifications
C; C07; C07H; C07H19/00; C07H19/02; C07H19/04; C07H19/16; C07H19/20; C07H19/207

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 34 words
A crystalline free acid type β-nicotinamide-adenine-dinucleotide tetrahydrate which is a triclinic system and has a space group of Pl or Pl and lattice constants: a=8.861 Å, b=11.181 Å, c=8.630 Å, α=90.82°, β=103.40° and γ=109.71°.
Claim 2
Dependent Claim 34 words
A crystalline free acid type β-nicotinamide-adenine-dinucleotide tetrahydrate which is a triclinic system and has a space group of Pl or Pl and lattice constants: a=8.861 Å, b=11.181 Å, c=8.630 Å, α=90.82°, β=103.40° and γ=109.71°.
Claim 3
Dependent Claim 56 words
A process for preparing crystalline free acid type β-nicotinamide-adenine-dinucleotide tetrahydrate in a triclinic system with a space group of Pl or Pl and lattice constants: a=8.861 Å, b=11.181 Å, c=8.630 Å, α=90.82°, β=103.40° and γ=109.71°, which comprises cooling a 20 to 60 w/v% aqueous solution of amorphous β-nicotinamide-adenine-dinucleotide at a temperature of 0° to 20° C.
Claim 4
Dependent Claim 56 words
A process for preparing crystalline free acid type β-nicotinamide-adenine-dinucleotide tetrahydrate in a triclinic system with a space group of Pl or Pl and lattice constants: a=8.861 Å, b=11.181 Å, c=8.630 Å, α=90.82°, β=103.40° and γ=109.71°, which comprises cooling a 20 to 60 w/v% aqueous solution of amorphous β-nicotinamide-adenine-dinucleotide at a temperature of 0° to 20° C.
Claim 5
Dependent Claim 19 words
The process of claim 2, wherein said amorphous β-nicotinamide-adenine-dinucleotide has a purity of at least 90% by enzymatic analysis.
Claim 6
Dependent Claim 25 words
The process of claim 2, wherein said amorphous β-nicotinamide-adenine-dinucleotide is one purified by treatment with an acetate type high porous weakly basic anion exchange resin.
Claim 7
Dependent Claim 42 words
A process for preparing amorphous β-nicotinamide-adenine-dinucleotide which comprises dissolving crystalline free acid type β-nicotinamide-adenine-dinucleotide tetrahydrate in water, and recovering β-nicotinamide-adenine-dinucleotide in solid form by means of either freeze drying or preciptiation with an alcohol followed by separation and drying of the precipitate.
Claim 8
Dependent Claim 42 words
A process for preparing amorphous β-nicotinamide-adenine-dinucleotide which comprises dissolving crystalline free acid type β-nicotinamide-adenine-dinucleotide tetrahydrate in water, and recovering β-nicotinamide-adenine-dinucleotide in solid form by means of either freeze drying or preciptiation with an alcohol followed by separation and drying of the precipitate.

References Cited (Backward Citations)

US3435026A Cited
US3700654A Cited
US4148994A Cited
US4151349A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1988-05-06 1988-11-05 1989-05-07 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1992-05-06 1992-11-05 1993-05-07 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1996-05-06 1996-11-05 1997-05-07 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag